Abstract:Background/Objectives: Osteoarthritis (OA) is a prevalent and debilitating joint disorder characterized by progressive cartilage degradation and inflammation, for which traditional treatments offer only symptomatic relief without halting disease progression. Exosomes, cell-free vesicles derived from mesenchymal stem cells, have emerged as a promising alternative therapy owing to their regenerative and anti-inflammatory properties. Methods: This review synthesizes findings from recent studies (2017–2023) on the therapeutic potential of exosomes in OA treatment, highlighting their ability to modulate the joint microenvironment, reduce inflammation, and promote cartilage repair by delivering bioactive molecules such as cytokines, growth factors, and regulatory ribonucleic acids. Results: We explore the integration of exosomes with biomaterials, such as hydrogels and scaffolds, to enhance their delivery and therapeutic efficacy, and we address the critical challenges associated with their clinical application, including standardization of isolation and characterization methods, scalability of production, mechanistic understanding, and long-term safety. Despite these challenges, exosome-based therapies offer several advantages over traditional and cell-based treatments, including lower immunogenicity, ease of handling, and targeted delivery of therapeutic agents to damaged tissues. Conclusions: We provide an analytical perspective on the current state of exosome research in OA, emphasizing the need for standardized production methods, deeper mechanistic insights, and rigorous long-term safety assessments. Future directions should focus on optimizing delivery systems, exploring personalized medicine approaches, and conducting comparative effectiveness studies to fully realize the potential of exosome therapies for OA treatment. Addressing these gaps will be crucial for translating exosome therapies from bench to bedside and achieving a transformative impact on OA management.

Harnessing exosomes as cutting-edge drug delivery systems for revolutionary osteoarthritis therapy

Harnessing exosomes for advanced osteoarthritis therapy

Exosomes in the Pathogenesis, Progression, and Treatment of Osteoarthritis

Exosome-Mediated Drug Delivery for Cell-Free Therapy of Osteoarthritis

The role of exosomes and their enhancement strategies in the treatment of osteoarthritis

Advancing Osteoarthritis Treatment: The Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes and Biomaterial Integration

Exosomes May Be the Potential New Direction of Research in Osteoarthritis Management.

Exosomes Rewire the Cartilage Microenvironment in Osteoarthritis: from Intercellular Communication to Therapeutic Strategies

Exosomes derived from MSC as drug system in osteoarthritis therapy

Enhancement of the therapeutic efficacy of mesenchymal stem cell-derived exosomes in osteoarthritis

Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis

Exosomes in osteoarthritis: Updated insights on pathogenesis, diagnosis, and treatment

The application of exosomes in the early diagnosis and treatment of osteoarthritis

Mesenchymal Stem Cell-Derived Exosomes as a Treatment Option for Osteoarthritis

Engineering of MSC-Derived Exosomes: A Promising Cell-Free Therapy for Osteoarthritis

Extracellular vesicles: Potential role in osteoarthritis regenerative medicine

Exosomes Reshape the Osteoarthritic Defect: Emerging Potential in Regenerative Medicine–A Review

Unlocking the potential of exosomes: a breakthrough in the theranosis of degenerative orthopaedic diseases

A new frontier in temporomandibular joint osteoarthritis treatment: Exosome-based therapeutic strategy.

Advances in the Study of Exosomes as Drug Delivery Systems for Bone-Related Diseases

Exosomes Derived from Non-Classic Sources for Treatment of Post-Traumatic Osteoarthritis and Cartilage Injury of the Knee: In Vivo Review